Skip to content
Prev 276314 / 398506 Next

Kaplan Meier - not for dates

Thanks for the reply.

The treatment is effectively for a chronic condition - so you stay on the treatment till it stops working.  We know from trials how long that should be and we know the theoretical cost of that treatment but that's based on the text book dose (patients dose reduce and delay treatment and its based on weight so variable).  We've been asked to provide our national planning team with an "average" cost based on our early experiences. So we have suggested to them we might be able to get a median cost.  Some patients will stay on treatment several years so it will be impossible to get an average for years.

So the censored patients will be those still on treatment (the event being stopping treatment)

I'll give what you've suggested a go.

Thanks


Calum Polwart BSc(Hons) MSc MRPharmS SPres IPres
Network Pharmacist - NECN and Pharmacy Clinical Team Manager (Cancer & Aseptic Services) - CDDFT
Our website has now been unlocked and updated.  Should you require contacts, meeting details, publications etc, please visit us on www.cancernorth.nhs.uk